Online Marketing Tools

Biotech stocks face volatility but boast long-term potential. In 2020, it was the year for growth-oriented health care names as the world came to grips with coronavirus and hungered for potential treatments. But in 2021, as the pandemic matured and as some of the COVID-related successes were priced in, we saw many areas take a step back – including the once-popular sector of biotechnology.

Scientists and vaccine makers are investigating Omicron, a Covid-19 variant that has been detected in many countries after spreading in southern Africa. Here is what we know as the U.S. and others implement travel restrictions. Agency and drugmakers develop testing and manufacturing guidelines in case they are needed for fight against new Covid-19 variant.